InvestorsHub Logo
Post# of 596859
Next 10
Followers 972
Posts 383067
Boards Moderated 5
Alias Born 06/24/2011

Re: None

Tuesday, 02/21/2017 8:59:02 AM

Tuesday, February 21, 2017 8:59:02 AM

Post# of 596859
$IMLFF the company is continuing drug/disease target identification using their proprietary bioinformatics analysis tool, More robust analysis of existing datasets to ensure that their clinical development plans are accurate and positioned to maximize the likelihood for positive outcomes, Validation and advancement of the biosynthesis manufacturing process; filing of provisional patents to commercially protect this key invention, Expanded scope of opportunities for cannabinoid-based drugs by validating new drug/disease targets in in vitro and in vivo efficacy model
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.